187 related articles for article (PubMed ID: 27736047)
1. Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.
Richardson CM; Davis EA; Vyas GR; DiPaula BA; McMahon RP; Kelly DL
J Clin Psychiatry; 2016 Nov; 77(11):e1454-e1459. PubMed ID: 27736047
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.
Maher KN; Tan M; Tossell JW; Weisinger B; Gochman P; Miller R; Greenstein D; Overman GP; Rapoport JL; Gogtay N
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):110-6. PubMed ID: 23510445
[TBL] [Abstract][Full Text] [Related]
3. Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events.
Demler TL; Morabito NE; Meyer CE; Opler L
Int Clin Psychopharmacol; 2016 Mar; 31(2):76-83. PubMed ID: 26565383
[TBL] [Abstract][Full Text] [Related]
4. Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review.
Midbari Y; Ebert T; Kosov I; Kotler M; Weizman A; Ram A
J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):516-21. PubMed ID: 24111981
[TBL] [Abstract][Full Text] [Related]
5. Safety of BEN guidelines in clozapine treatment: A Canadian perspective.
Wu S; Powell V; Chintoh A; Alarabi M; Agarwal SM; Remington G
Schizophr Res; 2024 Feb; 264():451-456. PubMed ID: 38262312
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.
Gee S; Taylor D
J Psychiatry Neurosci; 2021 Mar; 46(2):E232-E237. PubMed ID: 33703870
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.
Kelly DL; Glassman M; Wonodi I; Vyas G; Richardson CM; Nwulia E; Wehring HJ; Oduguwa T; Mackowick M; Hipolito MMS; Peters O; Rai N; Park J; Adebayo AO; Gorelick DA; Weiner E; Liu F; Kearns AM; Adams HA; Love RC; Chen S; Olaniyan A; Ambulos N; McKoy D; Nallani MC; Lanzkron S; Mengistab M; Barr B; Davis E; Lawal R; Buchanan RW; Adebayo R
Schizophr Res; 2024 Jun; 268():312-322. PubMed ID: 37633776
[TBL] [Abstract][Full Text] [Related]
8. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
9. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
10. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study.
Northwood K; Myles N; Clark SR; Every-Palmer S; Myles H; Kisely S; Warren N; Siskind D
Lancet Psychiatry; 2024 Jan; 11(1):27-35. PubMed ID: 38040009
[TBL] [Abstract][Full Text] [Related]
13. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
14. Risk of neutropenia among clozapine users and non-users: results from 5,847 patients.
Goldani AAS; Rabelo-da-Ponte FD; Feiten JG; Lobato MIR; Belmonte-de-Abreu PS; Gama CS
Braz J Psychiatry; 2022; 44(1):21-25. PubMed ID: 34730717
[TBL] [Abstract][Full Text] [Related]
15. Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals.
Oloyede E; Dzahini O; Barnes N; Mijovic A; Gandhi S; Stuart-Smith S; de Witte T; Taylor D; Whiskey E
BMC Psychiatry; 2021 Oct; 21(1):502. PubMed ID: 34645395
[TBL] [Abstract][Full Text] [Related]
16. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
Lau KL; Yim PH
East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
[TBL] [Abstract][Full Text] [Related]
17. Changes in Neutrophil Count After Antipsychotic Prescription Among a Retrospective Cohort of Patients With Benign Neutropenia.
Campion P; Campion G; Anbarasan D
J Clin Psychopharmacol; 2017 Aug; 37(4):456-458. PubMed ID: 28590372
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential effect of polypharmacy on the hematologic profiles of clozapine patients.
Shuman MD; Trigoboff E; Demler TL; Opler LA
J Psychiatr Pract; 2014 Jan; 20(1):50-8. PubMed ID: 24419309
[TBL] [Abstract][Full Text] [Related]
19. Ethnic neutropenia and clozapine.
Bray A
Aust N Z J Psychiatry; 2008 Apr; 42(4):342-5. PubMed ID: 18330777
[TBL] [Abstract][Full Text] [Related]
20. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
